Free Trial
LON:GSK

GSK (GSK) Share Price, News & Analysis

GSK logo
GBX 1,476 +7.00 (+0.48%)
As of 12:26 PM Eastern

About GSK Stock (LON:GSK)

Key Stats

Today's Range
1,462.50
1,478
50-Day Range
1,344
1,492.50
52-Week Range
1,242.50
1,678.68
Volume
1.86 billion shs
Average Volume
23.27 million shs
Market Capitalization
£59.56 billion
P/E Ratio
1,784.76
Dividend Yield
0.04%
Price Target
GBX 1,637.50
Consensus Rating
Hold

Company Overview

GSK Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
49th Percentile Overall Score

GSK MarketRank™: 

GSK scored higher than 49% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    GSK has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 2 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    GSK has only been the subject of 4 research reports in the past 90 days.

  • Read more about GSK's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of GSK is 1,784.76, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 276.92.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of GSK is 1,784.76, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 75.73.

  • Price to Earnings Growth Ratio

    GSK has a PEG Ratio of 1.24. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    GSK has a P/B Ratio of 4.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for GSK.
  • Dividend Leadership

    GSK is a leading dividend payer. It pays a dividend yield of 4.36%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    GSK does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of GSK is 74.97%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about GSK's dividend.
  • Short Interest

    There is no current short interest data available for GSK.
  • News Sentiment

    GSK has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for GSK this week, compared to 6 articles on an average week.
  • Search Interest

    37 people have searched for GSK on MarketBeat in the last 30 days. This is an increase of 9% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GSK insiders have bought more of their company's stock than they have sold. Specifically, they have bought £27,446.69 in company stock and sold GBX 0 in company stock.

  • Percentage Held by Insiders

    Only 0.20% of the stock of GSK is held by insiders.

  • Percentage Held by Institutions

    56.95% of the stock of GSK is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about GSK's insider trading history.
Receive GSK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GSK Stock News Headlines

Retire Comfortably with These New Monthly Income ETFs?
Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns just aren’t enough anymore. But what if you could reach your Freedom Number—the monthly income that makes retirement secure—using far less money than you thought possible? That’s exactly what Kelly G. discovered. She calls it “life-changing,” saying the income just keeps growing and that early retirement suddenly looks real. This strategy was once reserved for the ultra-wealthy, but it’s now available to everyday investors.tc pixel
Maze Therapeutics Appoints Misbah Tahir as Chief Financial Officer
MHRA approves GSK’s oral antibiotic for UTIs in females
GSK (LON:GSK) Receives "Buy" Rating from Shore Capital
See More Headlines

GSK Stock Analysis - Frequently Asked Questions

GSK's stock was trading at GBX 1,346.50 at the beginning of the year. Since then, GSK stock has increased by 9.6% and is now trading at GBX 1,476.

GSK plc (LON:GSK) announced its earnings results on Wednesday, July, 30th. The company reported $75.30 earnings per share (EPS) for the quarter. GSK had a net margin of 8.02% and a trailing twelve-month return on equity of 18.08%.

Shares of GSK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that GSK investors own include AstraZeneca (AZN), Vodafone Group Public (VOD), Lloyds Banking Group (LLOY), Secure Trust Bank (STB), Barclays (BARC), Meta Platforms (META) and Intel (INTC).

Company Calendar

Last Earnings
7/30/2025
Today
9/05/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
Pharmaceutical Products
Current Symbol
LON:GSK
CIK
N/A
Fax
N/A
Employees
70,212
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 2,100
Low Price Target
GBX 1,400
Potential Upside/Downside
+11.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX 0.83
Trailing P/E Ratio
1,782.95
Forward P/E Ratio
8.38
P/E Growth
1.24
Net Income
£2.50 billion
Net Margins
8.02%
Pretax Margin
N/A
Return on Equity
18.08%
Return on Assets
9.56%

Debt

Debt-to-Equity Ratio
114.64
Current Ratio
0.81
Quick Ratio
0.73

Sales & Book Value

Annual Sales
£31.63 billion
Price / Sales
1.88
Cash Flow
GBX 181.02 per share
Price / Cash Flow
8.15
Book Value
GBX 329.73 per share
Price / Book
4.47

Miscellaneous

Outstanding Shares
4,035,541,000
Free Float
N/A
Market Cap
£59.50 billion
Optionable
Not Optionable
Beta
0.31
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (LON:GSK) was last updated on 9/5/2025 by MarketBeat.com Staff
From Our Partners